AdaptHealth Statistics
Total Valuation
AdaptHealth has a market cap or net worth of $1.28 billion. The enterprise value is $3.10 billion.
| Market Cap | 1.28B |
| Enterprise Value | 3.10B |
Important Dates
The last earnings date was Tuesday, November 4, 2025, before market open.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AdaptHealth has 132.49 million shares outstanding. The number of shares has increased by 2.57% in one year.
| Current Share Class | 132.49M |
| Shares Outstanding | 132.49M |
| Shares Change (YoY) | +2.57% |
| Shares Change (QoQ) | +0.10% |
| Owned by Insiders (%) | 7.98% |
| Owned by Institutions (%) | 79.22% |
| Float | 88.01M |
Valuation Ratios
The trailing PE ratio is 17.64 and the forward PE ratio is 11.25.
| PE Ratio | 17.64 |
| Forward PE | 11.25 |
| PS Ratio | 0.40 |
| Forward PS | 0.37 |
| PB Ratio | 0.79 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 6.00 |
| P/OCF Ratio | 2.25 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.91, with an EV/FCF ratio of 14.55.
| EV / Earnings | 41.21 |
| EV / Sales | 0.95 |
| EV / EBITDA | 4.91 |
| EV / EBIT | 12.05 |
| EV / FCF | 14.55 |
Financial Position
The company has a current ratio of 1.08, with a Debt / Equity ratio of 1.17.
| Current Ratio | 1.08 |
| Quick Ratio | 0.69 |
| Debt / Equity | 1.17 |
| Debt / EBITDA | 2.71 |
| Debt / FCF | 8.93 |
| Interest Coverage | 2.32 |
Financial Efficiency
Return on equity (ROE) is 5.52% and return on invested capital (ROIC) is 4.45%.
| Return on Equity (ROE) | 5.52% |
| Return on Assets (ROA) | 3.64% |
| Return on Invested Capital (ROIC) | 4.45% |
| Return on Capital Employed (ROCE) | 6.94% |
| Revenue Per Employee | $310,020 |
| Profits Per Employee | $7,170 |
| Employee Count | 10,500 |
| Asset Turnover | 0.74 |
| Inventory Turnover | 18.09 |
Taxes
In the past 12 months, AdaptHealth has paid $66.65 million in taxes.
| Income Tax | 66.65M |
| Effective Tax Rate | 43.41% |
Stock Price Statistics
The stock price has decreased by -3.40% in the last 52 weeks. The beta is 1.78, so AdaptHealth's price volatility has been higher than the market average.
| Beta (5Y) | 1.78 |
| 52-Week Price Change | -3.40% |
| 50-Day Moving Average | 9.25 |
| 200-Day Moving Average | 9.26 |
| Relative Strength Index (RSI) | 54.62 |
| Average Volume (20 Days) | 1,179,156 |
Short Selling Information
The latest short interest is 9.65 million, so 7.28% of the outstanding shares have been sold short.
| Short Interest | 9.65M |
| Short Previous Month | 9.73M |
| Short % of Shares Out | 7.28% |
| Short % of Float | 10.97% |
| Short Ratio (days to cover) | 9.45 |
Income Statement
In the last 12 months, AdaptHealth had revenue of $3.26 billion and earned $75.29 million in profits. Earnings per share was $0.55.
| Revenue | 3.26B |
| Gross Profit | 699.95M |
| Operating Income | 257.49M |
| Pretax Income | 153.55M |
| Net Income | 75.29M |
| EBITDA | 632.45M |
| EBIT | 257.49M |
| Earnings Per Share (EPS) | $0.55 |
Balance Sheet
The company has $81.12 million in cash and $1.90 billion in debt, giving a net cash position of -$1.82 billion or -$13.76 per share.
| Cash & Cash Equivalents | 81.12M |
| Total Debt | 1.90B |
| Net Cash | -1.82B |
| Net Cash Per Share | -$13.76 |
| Equity (Book Value) | 1.62B |
| Book Value Per Share | 12.20 |
| Working Capital | 54.13M |
Cash Flow
In the last 12 months, operating cash flow was $569.00 million and capital expenditures -$355.83 million, giving a free cash flow of $213.17 million.
| Operating Cash Flow | 569.00M |
| Capital Expenditures | -355.83M |
| Free Cash Flow | 213.17M |
| FCF Per Share | $1.61 |
Margins
Gross margin is 21.50%, with operating and profit margins of 7.91% and 2.53%.
| Gross Margin | 21.50% |
| Operating Margin | 7.91% |
| Pretax Margin | 4.72% |
| Profit Margin | 2.53% |
| EBITDA Margin | 19.43% |
| EBIT Margin | 7.91% |
| FCF Margin | 6.55% |
Dividends & Yields
AdaptHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.57% |
| Shareholder Yield | -2.57% |
| Earnings Yield | 5.88% |
| FCF Yield | 16.66% |
Analyst Forecast
The average price target for AdaptHealth is $13.60, which is 40.93% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.60 |
| Price Target Difference | 40.93% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | 20.19% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AdaptHealth has an Altman Z-Score of 1.06 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.06 |
| Piotroski F-Score | 6 |